Clinical Trials Sponsored by CEG BIO LLC

Total 67 results

Human Stem Cell Institute, Russia
Betuvax LLC; CEG BIO LLC

Active, not recruiting

Safety, Tolerability and Immunogenicity of Recombinant COVID-19 Vaccine Betuvax-CoV-2 (Betuvax-CoV2)

COVID-19

Russian Federation
Cellf Bio LLC

Recruiting

Implantation of BioSphincter TM for Treatment of Severe Passive Fecal Incontinence

Fecal Incontinence

United States
Bio 54, LLC

Completed

Treatment of Post-Punch Biopsy Bleeding in Apixaban-Treated Patients Using Self-Administered BXP154B

Wound Bleeding

United States
Bio 54, LLC

Completed

Treatment of Post-Punch Biopsy Bleeding in Anticoagulated Patients Using Self-Administered BXP154

Wound Bleeding

United States
BIO-CAT Microbials, LLC
Prism Research LLC

Completed

Safety and Tolerability of Bacillus Subtilis MB40 in Healthy Adult Volunteers

Healthy Participants
Avobis Bio, LLC
Alimentiv Inc.

Recruiting

Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II)

Crohn's Disease | Perianal Fistula

United States
Viela Bio
MedImmune LLC

Completed

A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases

Dermatomyositis, Polymyositis, Sjogren's, SLE, SSc

United States
ESM Technologies, LLC
QPS Bio-Kinetic

Completed

NEM® + BIOCURC® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Exercise-induced Joint Pain | Exercise-induced Joint Stiffness | Exercise-induced Joint Cartilage Turnover

United States
National Cancer Institute (NCI)
Childrens Oncology Group (COG); LLS PedAL LLC

Recruiting

Highest Dose of Uproleselan in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Mixed Phenotype Acute Leukemia Relapsed or Refractory and That Expresses E-selectin Ligand on the Cell Membrane

Down Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Mixed Phenotype Acute Leukemia | Refractory Mixed Phenotype Acute Leukemia | Acute Myeloid Leukemia Post Cytotoxic Therapy | Myelodysplastic...

United States
Wellmarker Bio
Merck Sharp & Dohme LLC

Recruiting

Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)

Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Advanced Solid Tumor | Metastatic Solid Tumor

Korea, Republic of
Akamis Bio
Merck Sharp & Dohme LLC

Recruiting

Study of NG-350A Plus Pembrolizumab in Metastatic or Advanced Epithelial Tumours (FORTIFY) (FORTIFY)

Metastatic Cancer | Epithelial Tumor

United States, United Kingdom
ESM Technologies, LLC
QPS Bio-Kinetic

Completed

NEM® Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Exercise-induced Joint Pain | Exercise-induced Joint Stiffness | Exercise-induced Joint Cartilage Turnover

United States
Baudax Bio
Lotus Clinical Research, LLC

Completed

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery

Pain, Post-operative

United States
Baudax Bio
Lotus Clinical Research, LLC

Terminated

Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy

Pain, Post-operative

United States
AmMax Bio, Inc.
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer

Colorectal Cancer | Pancreatic Cancer | Non-Small Cell Lung Cancer

Canada, United States, Australia, Belgium, Spain, Germany
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate the Effect of GFA-918 on Serum Triglyceride Levels in Individuals With Elevated Serum Triglyceride

Elevated Triglycerides

Canada
BIO-CAT Microbials, LLC
KGK Science Inc.

Completed

A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

Bloating

United States, Canada
Qure Healthcare, LLC
CE Outcomes

Completed

Quality IQ Patient Simulation Physician Practice Measurement and Engagement (Q-IQ)

Depression | Heart Failure | Pain | Hypertension | Diabetes | Osteoarthritis | Asthma

United States
BIO-CAT Microbials, LLC
Biofortis Clinical Research, Inc.

Completed

Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults

Immune Health | Cardiovascular Health | Gastrointestinal Health | Digestive Health

United States
BIO-CAT Inc.
Atlantia Food Clinical Trials; Cork University Hospital

Completed

Effect of Candida Rugosa Lipase on Serum Triglyceride Lowering

Hypertriglyceridemia

Ireland
Hospital Reg. Lic. Adolfo Lopez Mateos

Unknown

Outpatient Treatment With CoVid-19 With Prexablu

Sars Cov 2

Mexico
Opna-IO LLC

Terminated

PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic Castration-resistant Prostate Cancer

United States, United Kingdom
Opna-IO LLC

Completed

A Study of PLX2853 in Advanced Malignancies.

Follicular Lymphoma | Small Cell Lung Cancer | Solid Tumor | Non-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Ovarian Clear Cell Carcinoma | Uveal Melanoma | Advanced Malignancies

United States
Opna-IO LLC

Completed

A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

High-risk Myelodysplastic Syndrome (MDS) | Relapsed Acute Myeloid Leukemia (AML) | Refractory Acute Myeloid Leukemia (AML)

United States
Opna-IO LLC

Terminated

PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer

Epithelial Ovarian Cancer | Gynecologic Neoplasms

United States, Canada
ESM Technologies, LLC
QPS Bio-Kinetic; KD Pharma Group

Completed

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women (Move3)

Exercise-induced Joint Pain | Exercise-induced Joint Stiffness | Exercise-induced Joint Cartilage Turnover

United States
CG Oncology, Inc.
Merck Sharp & Dohme LLC

Active, not recruiting

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin (CORE-001)

Non Muscle Invasive Bladder Cancer

United States, Korea, Republic of
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Not yet recruiting

S095035 in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of the Methylthioadenosine Phosphorylase (MTAP) Gene

MTAP-deleted Solid Tumors
GB006, Inc., a wholly owned subsidiary of Gossamer...
Merck Sharp & Dohme LLC

Terminated

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Renal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Triple Negative Breast Cancer | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Castration-resistant Prostate Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal Adenocarcinoma | Esophageal... and other conditions

United States, United Kingdom
Servier Bio-Innovation LLC
Merck Sharp & Dohme LLC; Institut de Recherches Internationales Servier

Not yet recruiting

A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers.

MSI-H/dMMR Gastroesophageal-junction Cancer | MSI-H/dMMR Gastric Cancer
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

A Phase 1, Open-Label Study to Evaluate the Effect of a Low-Fat Meal and Multiple Doses of Ciprofloxacin on the Pharmacokinetics of Vorasidenib in Healthy Subjects

Healthy Subjects

United States
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma

IDH1-mutant Cholangiocarcinoma

United States, United Kingdom
Servier Bio-Innovation LLC
Institut de Recherches Internationales Servier

Recruiting

A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors

Solid Tumor

Spain, Australia, Belgium, United States
BIO-CAT Microbials, LLC
Ohio State University; Biofortis Clinical Research, Inc.

Completed

The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults

Immune Health | Gastrointestinal Health | Digestive Health

United States
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Completed

Neoadjuvant Anti PD-1 Immunotherapy in Resectable Non-small Cell Lung Cancer (NEOMUN)

Non-small Cell Lung Cancer (NSCLC)

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Not yet recruiting

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome (HEAT)

Squamous Cell Carcinoma of the Larynx | Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Oropharynx | Squamous Cell Carcinoma of the Hypopharynx

Germany
AIO-Studien-gGmbH
Merck Sharp & Dohme LLC

Terminated

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) (PRIMUS)

Metastatic Squamous Non-small Cell Lung Cancer

Germany
BiO2 Medical
Novella Clinical; CardioMed Device Consultants, LLC; Intrinsic Imaging, LLC

Completed

The Angel® Catheter Pivotal Clinical Trial

Trauma | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
St. Renatus, LLC
Rho, Inc.; Triligent International; Analytical Bio-Chemistry Laboratories, Inc.

Completed

Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

Anesthesia

United States
Servier Bio-Innovation LLC
Regeneron Pharmaceuticals; Institut de Recherches Internationales Servier

Not yet recruiting

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

Non-small Cell Lung Cancer (NSCLC)
St. Renatus, LLC
Rho, Inc.; Triligent International; Analytical Bio-Chemistry Laboratories, Inc.

Completed

Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects

Anesthesia

United States
IO Biotech
Merck Sharp & Dohme LLC

Completed

IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC

NSCLC

United Kingdom, Germany, Netherlands, Spain
Hospital Reg. Lic. Adolfo Lopez Mateos
Instituto de Terapia Celular: ITC

Unknown

Mesenchymal Stem Cells in Patients Diagnosed With COVID-19

Covid19

Mexico
Cancer Insight, LLC
Bristol-Myers Squibb; Cancer Research Institute, New York City; Akamis Bio

Active, not recruiting

Exploratory Platform Trial to Evaluate Immunotherapy Combinations With Chemotherapy for the Treatment of Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma (REVOLUTION)

Metastatic Pancreatic Adenocarcinoma

United States
Chandrikha Chandrasekhara
TerSera Therapeutics LLC

Withdrawn

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl (NET-PACS)

Diarrhea | Neuroendocrine Tumors | Carcinoid Syndrome

United States
IO Biotech
Merck Sharp & Dohme LLC; Theradex; Almac

Recruiting

Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors

Melanoma | Squamous Cell Carcinoma of Head and Neck

United States, Australia, Denmark, Spain, France, Germany
IO Biotech
Merck Sharp & Dohme LLC; Syneos Health

Active, not recruiting

IO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)

Metastatic Melanoma | Unresectable Melanoma

Hungary, Spain, United Kingdom, Australia, France, Italy, United States, Denmark, Germany, Israel, Czechia, Belgium, Netherlands, Turkey, Poland, South Africa
Shadia Jalal, MD
AstraZeneca; MedImmune LLC; Big Ten Cancer Research Consortium

Completed

A Study of Durvalumab (MEDI4736) in Esophageal Cancer

Esophageal Cancer

United States
Manish Patel
Merck Sharp & Dohme LLC

Recruiting

Androgen Deprivation Therapy (ADT) and Pembrolizumab for Advanced Stage Androgen Receptor-positive Salivary Gland Carcinoma

Salivary Gland Carcinoma

United States
Greg Durm, MD
Merck Sharp & Dohme LLC

Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

NSCLC, Stage I

United States

Clinical Trials Sponsored by CEG BIO LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Latvia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations